Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV-infected T-cells and macrophages efficiently killed by new T-cell gene therapy

Oct. 16, 1997

PNU-140690: a novel HIV protease inhibitor in clinical testing at P&U

Oct. 14, 1997

Combined pharmacological/genetic strategy for HIV shows promise

Oct. 13, 1997

NIH approves study of marijuana in HIV-infected patients

Oct. 13, 1997

Boehringer Ingelheim presents compounds active against mutant HIV-1 RT

Oct. 9, 1997

Oligonucleotide compound in development for HIV-1 at Sankyo

Oct. 9, 1997

A-74259, an alpha-glucosidase inhibitor isolated from Streptomyces

Oct. 8, 1997

First long-term data for indinavir reported at ICAAC

Oct. 3, 1997

Fortovase compares favorably with Crixivan and Invirase

Oct. 2, 1997

Five efavirenz studies reported at ICAAC

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.